News

The first CRISPR Medicine Conference 2024

The First CRISPR Medicine Conference | 23-25 April 2024 | Copenhagen, Denmark

- Apr. 23, 2024
News

Stay updated here

Tags

HashtagEventsHashtagCRISPRMED24

CLINICAL TRIALS
Indicator
IND Enabling
Phase I
Phase II
Phase III
Metastatic Melanoma, (NCT06783270)
Sponsors:
Inge Marie Svane
Indicator
IND Enabling
Phase I
Phase II
Phase III
Systemic Lupus Erythematosus, SLE, (NCT06752876)
Sponsors:
Caribou Biosciences, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine